Women receive care designed for someone else, not for their actual bodies.
For generations, heart disease has claimed more women's lives than any other illness, yet medicine has largely treated it as a man's affliction — leaving women's symptoms unrecognized, their diagnoses delayed, and their treatments incomplete. This week, a coalition of European and international cardiologists published a formal call in the European Heart Journal for dedicated women's heart centers across Europe, offering both a diagnosis of the system's failure and a blueprint for repair. The centers already operating in North America and parts of Europe have shown that when women receive care designed around their actual biology, outcomes measurably improve. The question before European healthcare is no longer whether the problem exists, but whether the will to solve it does.
- Women die from heart disease at higher rates than men in part because medicine was built around a male template — their symptoms are routinely dismissed, their diagnoses arrive late, and recommended treatments are withheld at disproportionate rates.
- Cardiovascular risks unique to women — pregnancy complications, early menopause, autoimmune conditions — are systematically absent from standard risk assessments, creating invisible danger zones in routine care.
- A clinical consensus statement led by Dr. Julia Grapsa and published in the European Heart Journal this week demands that Europe establish specialized women's heart centers as referral hubs for complex, underdiagnosed cases.
- Evidence from existing centers in Canada, Switzerland, Germany, and the UK shows the model works: one Canadian facility diagnosed over 70 percent of women with unexplained cardiac symptoms and reduced their subsequent hospital admissions.
- Experts warn that centers alone are insufficient — medical education must be reformed to embed gender-specific cardiovascular knowledge, and continuous data auditing must ensure accountability over symbolic gesture.
Heart disease kills more women than any other condition — three in ten globally — yet it remains one of medicine's most persistent blind spots. Women arrive at hospitals with chest pain and leave without answers. They wait longer for diagnosis than men, and when the diagnosis finally comes, it often comes too late. The mortality gap is not a mystery; it is the measurable consequence of a system built around a male template.
This week, an international team of cardiologists led by Dr. Julia Grapsa published a clinical consensus statement in the European Heart Journal calling for dedicated women's heart centers across Europe. The problem, the authors argue, runs deeper than simple oversight. Women face cardiovascular triggers men do not — pregnancy complications, early menopause, autoimmune diseases — that standard risk assessments routinely ignore. Women are underrepresented in the clinical trials that shape medical practice, and less likely to receive guideline-recommended treatments.
The solution, however, already exists in prototype. Women's heart centers operating in Canada, Switzerland, Germany, and the United Kingdom have demonstrated striking results. One Canadian facility diagnosed more than 70 percent of women who arrived with unexplained cardiac symptoms; in the three years that followed, those women required fewer hospitalizations and had better outcomes.
The authors envision these centers not as replacements for general cardiology care, but as specialized referral hubs for complex cases — heart attacks where imaging finds no blockages, persistent angina, pregnancy-related cardiac complications, menopause-related heart conditions. They would also lead research, coordinate advanced diagnostics, and educate the broader medical community.
Dr. Martha Gulati of Houston Methodist cautioned that the centers are a framework, not a final answer, stressing that they must be paired with reformed medical education and rigorous data collection to prove impact and secure funding. Maria Rubini Gimenez of the European Society of Cardiology's Gender Task Force put the moment plainly: the EU has already recognized women's cardiovascular health as a public health priority. The work now is moving from recognition to implementation — building systems where women receive care suited to their actual bodies, not care designed for someone else.
Heart disease kills more women than any other condition—three in ten globally—yet it remains one of medicine's most persistent blind spots. Women arrive at hospitals with chest pain and leave without answers. Their symptoms get dismissed. They wait longer for diagnosis than men do. And when the diagnosis finally comes, it often comes too late. This gap between what women experience and what doctors see has real consequences: higher mortality rates, more serious illness, lives that could have been saved.
A clinical consensus statement published this week in the European Heart Journal calls for a direct response: Europe needs dedicated women's heart centers. The statement, authored by an international team of experts led by Dr. Julia Grapsa—a cardiologist who spent two decades practicing in Europe and now works at Mass General Brigham in Boston—lays out both the problem and a practical path forward.
The problem runs deeper than simple oversight. Women face cardiovascular triggers that men do not: pregnancy complications, early menopause, autoimmune diseases. These conditions are routinely absent from standard risk assessments. Women are underrepresented in the clinical trials that shape how doctors practice medicine. They are less likely to receive treatments that guidelines recommend. The result is a system of care built around a male template, one that leaves women's actual medical needs unmet.
But the solution exists. Women's heart centers already operate in parts of North America and in select European countries—Switzerland, Germany, the United Kingdom. The evidence from these centers is striking. One Canadian facility has diagnosed more than 70 percent of women who arrived with unexplained cardiac symptoms. In the three years following diagnosis, these women required fewer hospital admissions. They had better outcomes. They had answers.
The authors envision these centers as hubs embedded within existing cardiovascular care systems. They would not replace the work of general practitioners or standard cardiology clinics—most women would still receive routine care there. Instead, they would serve as specialized referral points for complex cases: heart attacks where traditional imaging has failed to find blockages, persistent angina, reduced blood flow to the heart that standard tests cannot explain. They would care for pregnant women with cardiovascular complications and for women navigating menopause-related heart conditions. They would lead research, coordinate advanced diagnostics, provide expert consultation, and educate the broader medical community.
Dr. Martha Gulati, director of the Davis Women's Heart Center at Houston Methodist, emphasized that these centers represent a framework, not a final answer. "We still need much more research on the best ways to diagnose and treat cardiovascular disease in women," she said, "but these centres will ensure that this type of research can flourish." The authors stress that the centers must be paired with fundamental change in medical education—every cardiologist should understand women's cardiovascular health, and those working in specialized centers need advanced training.
The statement also calls for continuous auditing. Data must be collected and analyzed to demonstrate impact, secure funding, and identify where improvements are needed. Without measurement, without accountability, the centers risk becoming symbolic gestures rather than tools for change.
Maria Rubini Gimenez, chair of the European Society of Cardiology's Gender Task Force, framed the moment clearly: the European Union has already recognized women's cardiovascular health as a public health priority. This statement is about moving from recognition to action. It is about building systems where women receive care suited to their actual bodies and their actual risks, not care designed for someone else. The work now is implementation—taking this blueprint and embedding it into the healthcare systems across Europe.
Notable Quotes
Women's symptoms are missed, they are less likely to receive guideline-recommended treatments, and they are underrepresented in the clinical trials that shape medical practice.— Dr. Julia Grapsa, lead author of the consensus statement
Women will receive care that is better suited to their needs, rather than being based around the male template that has dominated medicine and research for decades.— Maria Rubini Gimenez, Chair of the European Society of Cardiology's Gender Task Force
The Hearth Conversation Another angle on the story
Why does this matter now? Women's heart disease has existed for decades.
It matters now because the evidence is finally undeniable and because we have working models. We can see what works in Canada, in Switzerland, in Germany. We're not theorizing anymore.
But couldn't a regular cardiologist just learn to recognize these patterns?
In theory, yes. But medicine doesn't work that way. Without dedicated focus, without a center of expertise, the knowledge gets diluted. A busy cardiologist sees hundreds of patients. A women's heart center sees women with complex presentations all day. That concentration of attention changes outcomes.
The statement mentions pregnancy complications and menopause. Are those really heart problems?
They absolutely are. Preeclampsia during pregnancy can damage the heart. Early menopause changes cardiovascular risk in ways that standard risk assessments don't capture. These aren't edge cases—they're common conditions that affect millions of women and are routinely missed.
What happens if Europe doesn't do this?
Women keep dying from preventable disease. They keep arriving at hospitals with symptoms that doctors dismiss. The gap between men's outcomes and women's outcomes stays wide. It's a public health failure that's entirely addressable.
Is this just about fairness, or is there a practical argument?
Both. Yes, it's about equity—women deserve care that matches their actual medical needs. But it's also practical. A Canadian center diagnosed over 70 percent of women with unexplained symptoms. That's not charity. That's better medicine. That's fewer hospital admissions, better quality of life, lives saved.